Results 11 to 20 of about 2,125 (132)
Characteristics Associated with Depression Severity in 270 Juveniles in a Major Depressive Episode
Introduction: Severe depression is prevalent in young persons and can lead to disability and elevated suicidal risk. Objectives: To identify clinical and demographic factors associated with the severity of depression in juveniles diagnosed with a major ...
Giulia Serra+7 more
doaj +1 more source
Patterns of initiation of second generation antipsychotics for bipolar disorder: a month-by-month analysis of provider behavior [PDF]
Background: Several second generation antipsychotics (SGAs) received FDA approval for bipolar disorder in the 2000s. Although efficacious, they have been costly and may cause significant side effects.
Bajor, Laura+7 more
core +5 more sources
The role of NMDA receptors in bipolar disorder: A systematic review
Abstract Objectives Glutamatergic transmission and N‐methyl‐D‐aspartate receptors (NMDARs) have been implicated in the pathophysiology schizophrenic spectrum and major depressive disorders. Less is known about the role of NMDARs in bipolar disorder (BD).
Francesco Weiss+6 more
wiley +1 more source
Abstract Introduction Antidepressants are commonly used “off‐label” for bipolar depression, despite concerns over the risk of potential treatment‐emergent mania (or “manic switch”). Treatment‐emergent mania is difficult to study with adequate power in clinical trials as it requires a large group of participants and long follow‐up.
Oskar Hougaard Jefsen+2 more
wiley +1 more source
Effects of memantine on mania‐like phenotypes exhibited by Drosophila Shaker mutants
Amelioration of functional and metabolic parameters in Drosophila mutant upon memantine treatment. Abstract Introduction Increased glutamate levels and electrolytic fluctuations have been observed in acutely manic patients. Despite some efficacy of the non‐competitive NMDA receptor antagonist memantine (Mem), such as antidepressant‐like and mood ...
Ignazia Mocci+11 more
wiley +1 more source
Abstract Background There remain few efficacious treatments for bipolar depression, which dominates the course of bipolar disorder (BD). Despite multiple studies reporting associations between depression and cerebral blood flow (CBF), little is known regarding CBF as a treatment target, or predictor and/or indicator of treatment response, in BD ...
William S. H. Kim+16 more
wiley +1 more source
First‐line treatments for schizophrenia and schizoaffective disorder include antipsychotics and mood stabilizers, but their use may at times be limited due to severe adverse events. This case describes a 41‐year‐old male with a history of schizoaffective disorder and polysubstance use who was admitted to an inpatient psychiatry unit for acute manic and
David S. Im+3 more
wiley +1 more source
A systematic review and meta‐analysis of treatments for rapid cycling bipolar disorder
Abstract Objectives Rapid cycling is a common and disabling phenomenon in individuals with bipolar disorders. In the absence of a recent literature examination, this systematic review and meta‐analysis aimed to synthesise the evidence of efficacy, acceptability and tolerability of treatments for individuals with rapid cycling bipolar disorder (RCBD ...
Rebecca Strawbridge+6 more
wiley +1 more source
The effect of neuropsychiatric medication on pediatric nonalcoholic fatty liver disease
Abstract Obese and overweight children are at risk of developing nonalcoholic fatty liver disease (NAFLD), which can lead to steatohepatitis, cirrhosis, and liver transplantation. Neuropsychiatric conditions affect an increasing proportion of children and often require neuropsychiatric medications (NPMs) that are associated with weight gain and/or drug‐
Jamie L. Ryan+6 more
wiley +1 more source
Psychotropic medication use and Parkinson's disease risk amongst older women
Abstract Objective To examine associations of antidepressant, anxiolytic and hypnotic use amongst older women (≥65 years) with incident Parkinson's Disease (PD), using data from Women's Health Initiative linked to Medicare claims. Methods PD was defined using self‐report, first diagnosis, medications and/or death certificates and psychotropic ...
Hind A. Beydoun+9 more
wiley +1 more source